{{cart_num}}
My CartCAS：1051375-10-0
Molecular Formula：C19H17F2N3O5
Molecular Weight：405.35
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：≥98%
Appearance：White to off-white Solid
Qty：
Size：
| CAS | 1051375-10-0 |
| Name | Cabotegravir |
| Molecular Formula | C19H17F2N3O5 |
| Molecular Weight | 405.35 |
| Solubility | Soluble in DMSO |
| Purity | ≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| MDL | MFCD25976748 |
| SMILES | FC1=C(CNC(C2=CN3C(C(N([C@@H](C)CO4)[C@@]4([H])C3)=O)=C(O)C2=O)=O)C=CC(F)=C1 |
| Target Point | HIV integrase |
| Passage | Anti-infection |
| Background | Cabotegravir (CAB;GSK1265744) is a potent HIV Integrase Inhibitor in clinical development as an oral lead-in tablet and long-acting injectable for the treatment and prevention of HIV Infection.Cabotegravir (CAB;GSK1265744 or GSK744) long acting is an integrase strand transfer inhibitor that is an effective PrEP agent against rectal and vaginal simian/human immunodeficiency virus transmission in macaques.[1-2] |
| Unit | Bottle |
| Specification | 10mg 25mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
